£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

US Proliferative Diabetic Retinopathy Treatment Outlook 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 24 days · 24 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 03 August 2026 08 August 2026 14 August 2026 20 August 2026 26 August 2026
View at Amazon ↗

Price data last checked 67 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 24 days • 1 price levels

Days at Price
24 days 0 6 12 18 24 £520 Days at Price

Price Analysis

Most common price: £520 (24 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 24 days

Description

This comprehensive study provides a detailed outlook for proliferative diabetic retinopathy treatments within the United States from 2023 to 2028. It focuses on latent demand, expressed as potential industry earnings (P.I.E.) in millions of U.S. dollars. The data covers approximately 12,600 cities, offering a granular view of market opportunities across various states and municipalities. By providing the percent share of each city relative to its state and the nation, this report allows for effective comparative benchmarking. These statistical insights serve as a foundation for developing data-driven distribution and sales force strategies. This resource is designed for professionals needing precise market intelligence to navigate the evolving landscape of diabetic retinopathy treatments.

Key Features

Provides latent demand estimates for proliferative diabetic retinopathy treatments across 12,600 United States cities.

Includes potential industry earnings (P.I.E.) measurements expressed in millions of U.S. dollars.

Offers comparative benchmarks by reporting the percent share of each city relative to its state and the entire United States.

Supports sales force and distribution strategies through detailed statistical analysis of market demand.

Covers a specific market outlook period spanning from 2023 through 2028.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in China
99% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in China

£495.00 29 Oct 2026
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in Japan
99% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in Japan

£495.00 30 Oct 2026
The 2023-2028 Outlook for Diabetic Retinopathy Treatments in China
99% match

The 2023-2028 Outlook for Diabetic Retinopathy Treatments in China

£495.00 15 Aug 2026
The 2023-2028 Outlook for Diabetic Retinopathy Treatments in Japan
99% match

The 2023-2028 Outlook for Diabetic Retinopathy Treatments in Japan

£495.00 19 Aug 2026
Proliferative Diabetic Retinopathy Treatment Outlook 2023-2028
98% match

Proliferative Diabetic Retinopathy Treatment Outlook 2023-2028

£490.00 26 Aug 2026
US Macular Degeneration Treatment Outlook 2023-2028 Study
98% match

US Macular Degeneration Treatment Outlook 2023-2028 Study

£520.00 26 Aug 2026
Macular Degeneration Treatment Outlook in India 2023-2028
98% match

Macular Degeneration Treatment Outlook in India 2023-2028

£515.00 26 Aug 2026
The 2023-2028 Outlook for Uveitis Drugs in India
98% match

The 2023-2028 Outlook for Uveitis Drugs in India

£515.00 28 Aug 2026
The 2026-2031 World Outlook for Diabetic Macular Edema
97% match

The 2026-2031 World Outlook for Diabetic Macular Edema

£885.00 02 Sep 2026
Early Events in Diabetic Retinopathy and Intervention Strategies
97% match

Early Events in Diabetic Retinopathy and Intervention Strategies

IntechOpen

£113.24 01 Oct 2026
US Dry Eye Syndrome Treatment Outlook 2023-2028 Report
97% match

US Dry Eye Syndrome Treatment Outlook 2023-2028 Report

£520.00 22 Aug 2026
Diabetic Retinopathy: Methods and Protocols - Research Guide
97% match

Diabetic Retinopathy: Methods and Protocols - Research Guide

Humana

£106.00 02 Oct 2026
Pathobiology of Diabetic Retinopathy: Diabetes, Diabetic Retinopathy and Medicinal Plants
97% match

Pathobiology of Diabetic Retinopathy: Diabetes, Diabetic Retinopathy and Medicinal Plants

LAP Lambert Academic Publishing

£66.00 22 Sep 2026
The 2023-2028 Outlook for Dry Eye Syndrome Treatments in India
97% match

The 2023-2028 Outlook for Dry Eye Syndrome Treatments in India

£515.00 23 Aug 2026
The 2023-2028 Outlook for Eye Drops in India
97% match

The 2023-2028 Outlook for Eye Drops in India

£515.00 26 Aug 2026
The 2023-2028 Outlook for Macular Degeneration Treatments in Japan
97% match

The 2023-2028 Outlook for Macular Degeneration Treatments in Japan

£495.00 28 Oct 2026
The 2023-2028 Outlook for Myopia and Presbyopia Treatments in the United States
97% match

The 2023-2028 Outlook for Myopia and Presbyopia Treatments in the United States

£520.00 28 Oct 2026
The 2023-2028 Outlook for Vision Care in the United States
97% match

The 2023-2028 Outlook for Vision Care in the United States

£520.00 15 Aug 2026
The 2023-2028 Outlook for Anti-Vascular Endothelial Growth Factor Therapy (Anti-VEGF) for Non-Infectious Macular Edema in the United States
97% match

The 2023-2028 Outlook for Anti-Vascular Endothelial Growth Factor Therapy (Anti-VEGF) for Non-Infectious Macular Edema in the United States

£520.00 03 Oct 2026
Therapeutic Targets for Diabetic Retinopathy: A Translational Approach
97% match

Therapeutic Targets for Diabetic Retinopathy: A Translational Approach

Elsevier

£33.32 17 Sep 2026
Optic Nerve Disorders Treatment Outlook 2023-2028 Study
97% match

Optic Nerve Disorders Treatment Outlook 2023-2028 Study

£520.00 20 Aug 2026
The 2025-2030 World Outlook for Diabetic Macular Edema
97% match

The 2025-2030 World Outlook for Diabetic Macular Edema

Price unavailable
Diabetic Retinopathy - IntechOpen Medical Reference
97% match

Diabetic Retinopathy - IntechOpen Medical Reference

IntechOpen

£130.98 01 Oct 2026
US Diabetes Care Products Outlook 2023-2028 Market Study
97% match

US Diabetes Care Products Outlook 2023-2028 Market Study

£520.00 25 Aug 2026